Figure 2From: Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial Mean pain intensity in patients with rheumatoid arthritis treated with pelubiprofen 30 mg t.i.d. or celecoxib 200 mg b.i.d. as measured using a 100 mm visual analog scale (VAS). Bars represent standard deviations.Back to article page